VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,687,000 | +51.6% | 201,670 | +3.9% | 0.02% | +46.7% |
| Q1 2018 | $3,091,000 | -29.0% | 194,166 | -7.4% | 0.02% | -31.8% |
| Q4 2017 | $4,356,000 | +61.9% | 209,621 | +11.6% | 0.02% | +46.7% |
| Q3 2017 | $2,691,000 | +27.1% | 187,803 | +53.5% | 0.02% | +15.4% |
| Q2 2017 | $2,117,000 | +178.9% | 122,379 | +77.8% | 0.01% | +160.0% |
| Q1 2017 | $759,000 | +109.1% | 68,837 | +175.4% | 0.01% | +66.7% |
| Q4 2016 | $363,000 | -57.7% | 24,995 | -28.5% | 0.00% | -50.0% |
| Q3 2016 | $858,000 | +50.5% | 34,959 | +23.6% | 0.01% | +50.0% |
| Q2 2016 | $570,000 | -39.1% | 28,291 | -20.5% | 0.00% | -50.0% |
| Q1 2016 | $936,000 | -79.7% | 35,592 | -21.5% | 0.01% | -81.0% |
| Q4 2015 | $4,612,000 | -58.7% | 45,368 | -27.5% | 0.04% | -63.2% |
| Q3 2015 | $11,156,000 | -12.1% | 62,541 | +9.5% | 0.11% | -13.0% |
| Q2 2015 | $12,686,000 | +24.6% | 57,105 | +11.4% | 0.13% | +14.9% |
| Q1 2015 | $10,178,000 | +64.4% | 51,242 | +18.4% | 0.11% | +50.0% |
| Q4 2014 | $6,192,000 | +49.2% | 43,268 | +36.8% | 0.08% | +35.7% |
| Q3 2014 | $4,149,000 | +19.9% | 31,620 | +15.2% | 0.06% | +12.0% |
| Q2 2014 | $3,460,000 | -9.9% | 27,437 | -5.9% | 0.05% | -7.4% |
| Q1 2014 | $3,842,000 | +29.8% | 29,147 | +15.6% | 0.05% | +17.4% |
| Q4 2013 | $2,960,000 | +37.2% | 25,209 | +21.9% | 0.05% | +9.5% |
| Q3 2013 | $2,157,000 | +57.1% | 20,677 | +29.7% | 0.04% | +27.3% |
| Q2 2013 | $1,373,000 | – | 15,947 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |